A detailed history of Zimmer Partners, LP transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Zimmer Partners, LP holds 1,434,727 shares of ELDN stock, worth $5.55 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,434,727
Previous 2,109,704 31.99%
Holding current value
$5.55 Million
Previous $5.57 Million 35.86%
% of portfolio
0.07%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.41 - $3.19 $1.63 Million - $2.15 Million
-674,977 Reduced 31.99%
1,434,727 $3.57 Million
Q2 2024

Aug 14, 2024

BUY
$1.57 - $3.12 $3.31 Million - $6.58 Million
2,109,704 New
2,109,704 $5.57 Million

Others Institutions Holding ELDN

About Eledon Pharmaceuticals, Inc.


  • Ticker ELDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,756,800
  • Market Cap $53.2M
  • Description
  • Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...
More about ELDN
Track This Portfolio

Track Zimmer Partners, LP Portfolio

Follow Zimmer Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zimmer Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Zimmer Partners, LP with notifications on news.